HD-OPM Archive
Topics › LDL, ApoB & lipid panel

Nick Norwitz's eight statements on ApoB, keto, LMHR and the J-shaped curve

Louis Nervegna · Jul 23, 2024 · ♥ 10 reactions · 5 comments · original Facebook post
LDL, ApoB & lipid panelLow-carb, keto & carnivore
AI summary & key facts

The poster paraphrases the final hour of a Nick Norwitz interview: ApoB is causal and necessary for atherosclerosis but not alone sufficient; lowering it lowers risk; the J-shaped LDL mortality curve disappears after correcting for confounding and reverse causality. In LMHR, a distinct physiology may change absolute risk and the benefit of lowering ApoB is still unknown.

Here is a summary of Nick Norwitz’s 8 statements from the last hour of this video, which he believes are true.

These 8 statements summarize his research with Dave Feldman on keto, cholesterol, heart disease, LMHR, Oreos, and the “lipid energy model”.

(These are his words, not mine. The numbers are his. I am paraphrasing him as closely as possible, but usually not directly quoting him. I recommend actually listening to the last hour of the video if you have the time.)

  1. ApoB is causal of heart disease, and necessary for it to occur.

If you have zero ApoB, then atherosclerosis is not possible.

  1. ApoB alone is not sufficient for heart disease to occur.

Some people will have high ApoB but never develop atherosclerosis.

LMHR is a case where the question of whether high ApoB alone is sufficient is currently being tested in an on-going prospective cohort study.

  1. All things being equal, lowering ApoB will tend to lower CVD risk.
  1. Lowering ApoB is not needed for all patients with high ApoB, in part, because all interventions come with trade offs.
  1. Lower levels of ApoB can associate with higher all cause mortality.

This is the famous J-shaped curve for LDL. This J-shaped curve disappears when you properly account for confounders and reverse causality. After these corrections, what you then see is that lower ApoB is associated with lower all-cause mortality. Nick explains all of this.

  1. The act of reducing ApoB can causally reduce mortality and extend healthspan.
  1. The LMHR phenotype represents unique physiological causes of high ApoB, and this underlying physiology may impact absolute risk.

He clarifies that he is not saying that the TG/HDL ratio is causally protective by itself. It’s the LMHR phenotype as a whole that might allow for higher ApoB without the same size increase in risk that you would see in the general population.

  1. In LMHR as a specific subpopulation, the absolute benefits of lowering ApoB are unknown and more information is needed to better tailor individual care.

#lmhrHD #norwitzHD

▶Video · YouTube · The Proof with Simon HillKeto & Cholesterol: Lipid Energy Model and the Oreo Experiment | Nick Norwitz | The ProofNick Norwitz, PhD is a 28-year-old 4th year medical student at Harvard Medical School. Prior to pursuing a career in medicine, he attended Dartmouth College where he majored in Cell Biology and Biochemistry and graduated Valedictorian. He then went on to complete a PhD at the University of Oxford in Neuro-Metabolism before returning to Boston to complete…youtu.be

Research cited

← newer: Ornish program now allows nuts and seeds, citing 30-50% loweolder: Why LMHR happens: starvation-like physiology in very lean pe →